Paper

Clinical implications of identifying pathogenic variants in aortic dissection patients with whole exome sequencing

Driscoll, Anisa, Douville, Nicholas J, Deeb, Michael, Farhat, Linda, Kitzman, Jacob, Patel, Himanshu, Schmidt, Ellen M, Ganesh, Santhi K, Milewicz, Dianna M, Guo, Dongchuan, Zhou, Wei, Mcnamara, Jennifer, Chen, Y Eugene, Mathis, Michael R, Eagle, Kim A, Hornsby, Whitney E, Kim, Karen, Wolford, Brooke N, Yang, Bo, Norton, Elizabeth L, Lin, Maoxuan, Brummett, Chad M, Willer, Cristen J, Wu, Xiaoting

2018

Overview

Background: Thoracic aortic dissection is an emergent life-threatening condition. Routine screening for genetic variants causing thoracic aortic dissection is not currently performed for patients or their family members. Methods: We performed whole exome sequencing of 240 patients with thoracic aortic dissection (n=235) or rupture (n=5) and 258 controls matched for age, sex, and ancestry. Blinded to case-control status, we annotated variants in 11 genes for pathogenicity. Results: Twenty-four pathogenic variants in 6 genes (COL3A1, FBN1, LOX, PRKG1, SMAD3, TGFBR2) were identified in 26 individuals, representing 10.8% of aortic cases and 0% of controls. Among dissection cases, we compared those with pathogenic variants to those without and found that pathogenic variant carriers had significantly earlier onset of dissection (41 vs. 57 years), higher rates of root aneurysm (54% vs. 30%), less hypertension (15% vs. 57%), lower rates of smoking (19% vs. 45%), and greater incidence of aortic disease in family members. Multivariable logistic regression showed significant risk factors associated with pathogenic variants are age <50 [odds ratio (OR) = 5.5; 95% CI: 1.6-19.7], no history of hypertension (OR=5.6; 95% CI: 1.4-22.3) and family history of aortic disease (mother: OR=5.7; 95% CI: 1.4-22.3, siblings: OR=5.1; 95% CI 1.1-23.9, children: OR=6.0; 95% CI: 1.4-26.7). Conclusions: Clinical genetic testing of known hereditary thoracic aortic dissection genes should be considered in patients with aortic dissection, followed by cascade screening of family members, especially in patients with age-of-onset of aortic dissection <50 years old, family history of aortic disease, and no history of hypertension.

• Publisher: Cold Spring Harbor Laboratory Press,Cold Spring Harbor Laboratory
• Subject: Aneurysms / Children / Dissection / Family medical history / Genetic diversity / Genetic screening / Genetics / Hypertension / Pathogenicity / Risk factors / Smad3 protein / Smoking / Thorax